Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough?

Breast Cancer Res Treat. 2021 Jan;185(1):255-256. doi: 10.1007/s10549-020-05923-9. Epub 2020 Sep 14.

Authors

Michela Palleschi¹, Emanuela Scarpi¹, Chiara Casadei²

Affiliations

¹ Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (IRST) IRCCS, via Piero Maroncelli 40, 47014, Meldola, Italy.
² Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (IRST) IRCCS, via Piero Maroncelli 40, 47014, Meldola, Italy. chiara.casadei@irst.emr.it.

PMID: 32929569
DOI: 10.1007/s10549-020-05923-9

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Body Mass Index
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans